AAAAAA

   
Results: 1-7 |
Results: 7
Busulfan levels are influenced by prior treatment and are associated with hepatic veno-occlusive disease and early mortality but not with delayed complications following marrow transplantation
Authors: Copelan, EA Bechtel, TP Avalos, BR Elder, PJ Ezzone, SA Scholl, MD Penza, SL
Citation: Ea. Copelan et al., Busulfan levels are influenced by prior treatment and are associated with hepatic veno-occlusive disease and early mortality but not with delayed complications following marrow transplantation, BONE MAR TR, 27(11), 2001, pp. 1121-1124
NCCN Practice Guidelines for chronic myelogenous leukemia
Authors: Talpaz, M Berman, E Clift, RA Copelan, EA Emanuel, PD Erba, HP Glenn, MJ Greenberg, PL Jones, RJ O'Brien, S Saba, HI Schilder, R Snyder, DS Soiffer, RJ Tallman, MS Wetzler, M Ravandi-Kashani, F Kantarjian, H Talpaz, M
Citation: M. Talpaz et al., NCCN Practice Guidelines for chronic myelogenous leukemia, ONCOLOGY-NY, 14(11A), 2000, pp. 229-240
The influence of early transplantation, age, GVHD prevention regimen, and other factors on outcome of allogeneic transplantation for CML following BuCy
Authors: Copelan, EA Penza, SL Theil, KS Elder, PJ Bechtel, TP Tighe, MB Ezzone, SA Scholl, MD Belt, PS Young, DC Avalos, BR
Citation: Ea. Copelan et al., The influence of early transplantation, age, GVHD prevention regimen, and other factors on outcome of allogeneic transplantation for CML following BuCy, BONE MAR TR, 26(10), 2000, pp. 1037-1043
Analysis of prognostic factors for allogeneic marrow transplantation following busulfan and cyclophosphamide in myelodysplastic syndrome and after leukemic transformation
Authors: Copelan, EA Penza, SL Elder, PJ Ezzone, SA Scholl, MD Bechtel, TP Belt, PS Avalos, BR
Citation: Ea. Copelan et al., Analysis of prognostic factors for allogeneic marrow transplantation following busulfan and cyclophosphamide in myelodysplastic syndrome and after leukemic transformation, BONE MAR TR, 25(12), 2000, pp. 1219-1222
Autotransplantation following busulfan, etoposide and cyclophosphamide in patients with non-Hodgkin's lymphoma
Authors: Copelan, EA Penza, SL Pohlman, B Avalos, BR Goormastic, M Andresen, SW Kalaycio, M Bechtel, TP Scholl, MD Elder, PJ Ezzone, SA O'Donnell, LC Tighe, MB Risley, GL Young, DC Bolwell, BJ
Citation: Ea. Copelan et al., Autotransplantation following busulfan, etoposide and cyclophosphamide in patients with non-Hodgkin's lymphoma, BONE MAR TR, 25(12), 2000, pp. 1243-1248
Are busulfan-based preparative regimens equivalent, worse, or better than total body irradiation regimens?
Authors: Copelan, EA
Citation: Ea. Copelan, Are busulfan-based preparative regimens equivalent, worse, or better than total body irradiation regimens?, CUR CLIN ON, 2000, pp. 53-67
Should all adult patients with acute lymphoblastic leukemia in first remission undergo allogeneic bone marrow transplantation?
Authors: Penza, SL Copelan, EA
Citation: Sl. Penza et Ea. Copelan, Should all adult patients with acute lymphoblastic leukemia in first remission undergo allogeneic bone marrow transplantation?, CUR CLIN ON, 2000, pp. 95-105
Risultati: 1-7 |